Codexis, Inc. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Codexis, Inc. on September 8, 2022, with the earliest event reported dated October 3, 2022. The filing discloses significant corporate governance changes, specifically the appointment of a new Chief Operating Officer and a new independent director to the Board of Directors.
Key Financial Metrics
The filing does not provide revenue, profit, cash flow, margin, debt, or liquidity metrics. This report focuses exclusively on executive compensation and board appointments.
Material Changes and Appointments
- Appointment of Chief Operating Officer: Kevin Norrett, M.B.A., was appointed as Chief Operating Officer, effective October 3, 2022.
- Compensation: Annual base salary of $450,000 with a target bonus of 50% of base salary.
- Equity Grants: Stock options with a grant date fair value of approximately $1,333,333 (vesting 25% after one year, then monthly) and performance stock units with a grant date fair value of approximately $666,667.
- Severance: Entitled to 12 months of base salary and healthcare if terminated without cause or resigns for good reason outside a change in control window. In the event of a change in control, severance increases to 18 months of salary and healthcare, plus full accelerated vesting of equity.
- Board Appointment: Rahul Singhvi, Sc.D., was appointed as a Class I independent director on September 28, 2022.
- Compensation: Annual cash retainer of $50,000 plus committee retainers.
- Equity Grants: Initial grant of 31,347 restricted stock shares vesting over three years. Future annual grants valued at $100,000 vesting within one year.
Outlook, Risks, and Contingencies
The filing does not contain forward-looking guidance, risk factors, or unusual items beyond the standard terms of the employment and director agreements. The agreements are subject to the execution of a general release of claims for severance benefits to be paid.
Investor Verification Checklist
- Verify the exact vesting schedules and performance metrics for Mr. Norrett's performance stock units in the full Offer Letter.
- Confirm the total number of shares underlying Mr. Norrett's stock option grant once the grant date is finalized.
- Review the full Change of Control and Severance Agreement for specific definitions of "cause" and "good reason."
- Check the upcoming Form 10-Q for the quarter ending September 30, 2022, where the full agreements will be filed as exhibits.